A Comparison of Synthetic Osmotic Dilators and Pharmacologic Agents for Cervical Ripening in Induction of Labor: A Systematic Review and Meta-Analysis.
Gi Wook Ryu, Sun-Young Park
PMID 40920130WHAT IT FOUND
Synthetic osmotic dilators match pharmacologic agents for vaginal birth rates but cause less uterine hyperstimulation and digestive symptoms.
However, they require more additional procedures like artificial rupture of membranes. Overall maternal infection risk showed no significant difference.
Key findings
01Synthetic osmotic dilators significantly reduced the risk of uterine hyperstimulation compared to pharmacologic agents.
02There was no significant difference in vaginal birth rates or overall maternal infection rates between synthetic osmotic dilators and pharmacologic agents.
03The need for additional procedures was significantly higher with synthetic osmotic dilators than with pharmacologic agents.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The included studies span three decades (1992-2022), meaning older studies may not reflect current clinical practices or infection control standards. There was significant heterogeneity in study characteristics, including gestational age, parity, Bishop scores, and the specific methods of dilator application and duration. The review could not adequately assess the effects of combining synthetic osmotic dilators with pharmacologic agents due to a limited number of studies. Only English-language studies were included, which may have excluded relevant international data.
Declared interests
The authors declared no conflicts of interest.
The easy way to misread this
Do not assume synthetic osmotic dilators are a 'hands-off' option. While they reduce hyperstimulation risk, they are associated with a significantly higher need for additional procedures like artificial rupture of membranes, which may prolong the induction process or require more active clinical management.